Clinical Trial Update: Chinese Assessment for Vinpocetine In Neurology

View source ↗

Summary

A completed Chinese clinical trial evaluating vinpocetine for cerebral infarction in neurology, sponsored by Shanghai Rxmidas Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction

Drugs mentioned

• Vinpocetine (vinpocetine)

Snippet

Sponsor: Shanghai Rxmidas Pharmaceuticals Co. Ltd. | Conditions: Cerebral Infarction | Status: COMPLETED